v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
Mar. 31, 2014
Dec. 31, 2013
Current Assets    
Cash $ 257,415 $ 2,856
Accounts receivable, net 143,527 323,965
Inventories 222,061 273,195
Prepaid and other current assets 344,039 226,217
Assets of discontinued operations 7,767 4,048
Total current assets 974,809 830,281
Property and equipment, net 81,205 78,094
Assets of discontinued operations, net 137,470 140,563
TOTAL ASSETS 1,193,484 1,048,938
Current Liabilities    
Accounts payable and accrued expenses 1,546,549 1,642,518
Liabilities of discontinued operations 122,387 150,652
Unsecured convertible debentures, net of discount 382,155 357,528
Notes payable to related parties 240,000   
Notes payable 3,864,519 3,830,637
Total current liabilities 6,155,610 5,981,355
Notes payable, net of current portion. 17,474 25,882
Notes payable to related parties, net of current portion 677,000 477,000
Unsecured convertible debentures, net of current portion and discount 1,110,472 1,142,472
Derivative liability 250,046 312,088
Warrant liability 879,459 1,060,353
TOTAL LIABILITIES 9,090,061 8,999,130
Commitments and Contingencies (see Note 9)      
Series D redeemable convertible preferred stock; par value $0.001 per share;15,000 shares authorized, 1,926 and 1,070 issued and outstanding, respectively 3,177,526 2,515,469
Assured Pharmacy, Inc.Stockholders' Deficit    
Preferred stock; par value $0.001 per share; 5,000,000 shares authorized, 2,830 shares designated to Series A convertible, 7,745 shares designated to Series B convertible, 813 shares designated to Series C convertible      
Series A convertible preferred stock; par value $0.001 per share; 2,830 shares authorized, 1,466 and 1,466 issued and outstanding, respectively 1 1
Series C convertible preferred stock; par value $0.001 per share; 813 shares authorized, 813 and 813 issued and outstanding, respectively 1 1
Series B convertible preferred stock; par value $0.001 per share; 7,745 shares authorized, 5,124 and 5,124 issued and outstanding, respectively 5 5
Common stock; par value $0.001 per share; 100,000,000 shares authorized, 11,503,294 and 10,255,693 issued and outstanding, respectively 11,503 10,256
Additional paid-in capital, net 38,319,672 38,142,048
Accumulated deficit (49,405,285) (48,617,972)
Stockholders' deficit (11,074,103) (10,465,661)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 1,193,484 $ 1,048,938